Nicotine Metabolizers and [11C]-(+)-PHNO

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Study Completion Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the effects of nicotine metabolism on occupancy of \[11C\]-(+)-PHNO to DA 2/3 receptors in different brain areas during periods of abstinence and smoking during an abstinence. This will be a Positron Emission Tomography (PET) study and the radiotracer \[11C\]-(+)-PHNO (11C\]-( + )-4-propyl- 3,4,4a,5,6,10b-hexahydro-2H-naphtho\[1,2-b\]\[1,4\]oxazin-9-ol) will be used.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Varenicline on D2/D3 Receptor Binding in Smokers

NCT01632189

Nicotine Dependence

COMPLETED NA

Nicotinic Receptor Levels After Stopping Smoking

NCT01704573

Nicotine Addiction

COMPLETED

Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction

NCT03442413

Smoking, Tobacco

ACTIVE_NOT_RECRUITING PHASE1

Feasibility of PET/CT to Detect the Oral/Pulmonary Distribution of Nicotine Following E-cigarette Use

NCT03491059

E-cigarette Use

ACTIVE_NOT_RECRUITING PHASE4

Nicotine Receptor Levels and Smoking Cessation

NCT01788943

Smoking Cessation Nicotine Addiction

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The participants will undergo a PET scan after approximately 48 hours abstinence (to ensure total elimination of nicotine in both FMs and SMs) and then approximately \>5 hours later may have a second PET scan after smoking their preferred cigarette (approximately 1 hour before). It is possible that these two scans may also occur on separate days. All subjects will provide a urine sample for (1) drug toxicology, (2) pregnancy test (in females) and (3) Total Nicotine Equivalents (TNE: a measure of total consumption unaltered by rate of nicotine metabolism). There will one blood draw taken before and one after each PET scan (about 20mls in total) to measure nicotine and COT levels (to assess abstinence) as well as kinetics of nicotine delivery. Participants will be given questionnaires prior to, or during, and/or after one or both of the PET scans to determine differences between abstinence and smoking on subjective measures..

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nicotine Dependence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fast Nicotine Metabolizers

Those in the upper tertile of NMR for cigarette/nicotine metabolism.

Group Type OTHER

cigarette

Intervention Type OTHER

Participants will be allowed to smoke a cigarette prior to a PET scan and be abstinent from smoking prior to the other PET scan

Slow Nicotine Metabolizers

Those in the lower tertile of NMR for cigarette/nicotine metabolism

Group Type OTHER

cigarette

Intervention Type OTHER

Participants will be allowed to smoke a cigarette prior to a PET scan and be abstinent from smoking prior to the other PET scan

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cigarette

Participants will be allowed to smoke a cigarette prior to a PET scan and be abstinent from smoking prior to the other PET scan

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males and females of any ethnic origin 18 years of age or older.
* No previous use of medication for smoking cessation in previous month-
* Non-treatment seeker
* Either SMs or FMs by NMR

Exclusion Criteria

* DSM-IV diagnosis of other drug dependences
* Any medical condition requiring immediate investigation or treatment
* Pregnancy tested by urine or lactation by self-report
* Current diagnosis of any Axis I psychiatric disorder
* Regular use of any therapeutic or recreational psychoactive drug use that may interfere with PET scanning
* Exposure to radiation in the last 12 months exceding permissible limit for participants participating in research
* Current use of medication that may interfere with \[11C\]-(+)-PHNO
* Metal implants or paramagnetic objects within the body which may interfere with the MRI
* Claustrophobia or a history of panic attacks
* Having any clinical condition, drug sensitivity, or prior therapy which, in the investigator's opinion, makes the participant unsuitable for the study
* Current use of antidepressants that may inhibit CYP2A6 or impact response to nicotine

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes